| NASEM Forum on Neuroscience and Nervous System Disorders |
Committee, Work group, Advisory group, or Task Force |
FDA |
NCCIH, NIA, NIAAA, NIDA, NIEHS, NIMH, NINDS |
The National Academies of Sciences, Engineering, and Medicine (NASEM) Forum on Neuroscience and Nervous System Disorders was established to bring together leaders from government, industry, academia, and disease advocacy organizations to examine issues concerning scientific needs and policies related to neuroscience and nervous system disorders research and the development and use of interventions for the nervous system. The Forum also sponsors workshops for its members and the public on key challenges and issues in the field. |
| NASEM Forum on Traumatic Brain Injury |
Committee, Work group, Advisory group, or Task Force |
ACL, CDC |
NIA, NICHD, NINDS |
The National Academies of Sciences, Engineering, and Medicine (NASEM) Forum on Traumatic Brain Injury provides a setting for experts to discuss how to advance the prevention, treatment, and care for people with brain injuries. The TBI Forum addresses topics relating to critical research gaps, TBI treatment and rehabilitation, and other related needs and challenges. |
| NASEM Roundtable on Genomics and Precision Health |
Committee, Work group, Advisory group, or Task Force |
CDC, FDA, HRSA |
NCI, NHGRI, NIA, NIMH |
This roundtable brings together diverse voices to encourage innovation and actions that foster the wide adoption of and equitable access to the benefits of genomics and precision health. |
| NASEM Roundtable on Obesity Solutions |
Committee, Work group, Advisory group, or Task Force |
CDC |
NIDDK |
This Working Group includes representatives from the NIH, CDC, Academia, NGOs, and Industry. |
| National Academy of Medicine Committee on Emerging Science, Technology, and Innovation in Health and Medicine |
Committee, Work group, Advisory group, or Task Force |
FDA |
NIMH |
The National Academy of Medicine Committee on Emerging Science, Technology, and Innovation in health and medicine brings together experts in a range of fields to assess the landscape of emerging scientific advances and technologies in health and medicine and address the potential societal, ethical, legal, and workforce implications of such technologies. The goal of the Committee is to develop a multi-sectoral governance policy framework. The Committee plans to examine examples of emerging technologies and their implications for society, through a multi-sectoral lens. The first point of focus will be on neurotechnology, specifically transcranial direct current stimulation. |
| National Action Alliance for Suicide Prevention (NAASP) |
Committee, Work group, Advisory group, or Task Force |
ACL, CDC, HRSA, IHS, OS, OSG, SAMHSA |
NIAAA, NIMH, OD/DPCPSI/OBSSR |
Founded in September 2010, the National Action Alliance for Suicide Prevention (NAASP) is a public-private partnership designed to advance the National Strategy for Suicide Prevention in the United States. The NAASP's Research Prioritization Task Force (RPTF) was charged with developing a process to prioritize suicide prevention research efforts and consider ways to integrate science and service to ensure that suicide deaths decrease significantly within the next decade. The RPTF released the Nation's first suicide research agenda, A Prioritized Research Agenda for Suicide Prevention: An Action Plan to Save Lives. The research agenda includes an overarching goal to advance suicide prevention research more rapidly, seeking ways to reduce suicide deaths and attempts by 20 percent in five years and by 40 percent or greater in ten years. In 2015, the RPTF produced the "U.S. National Suicide Prevention Research Efforts: 2008-2013 Portfolio Analyses." The analyses revealed that investments in suicide research are severely lagging, but there is a growing knowledge base of intervention research. NIMH participates in a number of NAASP activities related to identifying research needs for improving risk identification and suicide preventive care within healthcare systems, justice, and school settings. |
| National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB) 2020-2025 |
Committee, Work group, Advisory group, or Task Force |
AHRQ, BARDA, CDC, CMS, FDA |
NIAID |
The National Action Plan for Combating Antibiotic-resistant Bacteria, 2020-2025, was developed through the CARB Task Force, now reporting coordinated, strategic actions that the U.S. government takes to reduce the impact of antibiotic and antimicrobial resistance on the nation. |
| National Advisory Board for Medical Rehabilitation Research |
Committee, Work group, Advisory group, or Task Force |
ACL, CDC |
NHLBI, NIA, NIAMS, NICHD, NIDCD, NINDS |
The Director of the National Institutes of Health (NIH) was mandated in P.L. 101-613 to establish the National Advisory Board on Medical Rehabilitation Research. The Board advises the directors of the NIH, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and NICHD's National Center for Medical Rehabilitation Research (NCMRR) on matters and policies relating to the NCMRR's programs. The Board is comprised of 12 members representing health and scientific disciplines related to medical rehabilitation and six members representing persons with disabilities. |
| National Advisory Committee on Seniors and Disasters |
Committee, Work group, Advisory group, or Task Force |
ASPR, ACL, BARDA, CDC, CMS |
NIA |
The National Advisory Committee on Seniors and Disasters (NACSD) will evaluate issues and programs and provide findings, advice, and recommendations to the Secretary of Health and Human Services to support and enhance all-hazards public health and medical preparedness, response, and recovery activities related to meeting the unique needs of older adults. |
| National ALS Registry |
Research Initiative |
CDC |
NIA |
Collaborative research project focused on understanding and treating amyotrophic lateral sclerosis, a neurodegenerative disease that kills 7000 Americans annually. |